Treat COVID-19 Patients With Regadenoson
NCT04606069
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Lung Inflammation
Interventions
DRUG:
Regadenoson
OTHER:
Placebo Control
Sponsor
University of Maryland, Baltimore